Loading…
Based on limited metadata, the FDA issued a Warning Letter to Baja Fur S.A. de C.V., a company involved in drug manufacturing or distribution, on December 13, 2019. Without access to the full letter text or subject line details, the specific nature of the regulatory violations cannot be determined from the available information. The letter falls under FDA's drug product oversight authority, though the issuing office is not specified in the metadata provided.